Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...

Daiichi Sankyo has emerged victorious in appeals court, flipping a prior multibillion-dollar patent verdict on its head and ...

The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...

The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...

As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug ...

Two-thirds of respondents who have faced fertility challenges said their workplaces don’t offer support for employees undergoing fertility treatment. Support is rarest in France, where 88% of ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Daniel McIver spoke about the challenges and rewards of his ...

Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow ...

Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...

The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...